TGAM
BMY icon

TBH Global Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

TBH Global Asset Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$434K Sell
7,160
-777
-10% -$45.3K 0.09% 188
2025
Q4 		$428K Buy
7,937
+681
+9% +$32.8K 0.07% 179
2025
Q3 		$327K Sell
7,256
-1,674
-19% -$78.2K 0.06% 209
2025
Q2 		$413K Buy
8,930
+57
+0.6% +$2.8K 0.09% 139
2025
Q1 		$541K Buy
8,873
+51
+0.6% +$2.97K 0.1% 120
2024
Q4 		$499K Buy
8,822
+2
+0% +$112 0.12% 144
2024
Q3 		$456K Sell
8,820
-787
-8% -$36.9K 0.1% 165
2024
Q2 		$399K Sell
9,607
-49
-0.5% -$2.19K 0.09% 173
2024
Q1 		$524K Buy
9,656
+906
+10% +$46.2K 0.1% 152
2023
Q4 		$449K Sell
8,750
-20,196
-70% -$1.06M 0.09% 160
2023
Q3 		$1.68M Sell
28,946
-344
-1% -$21.1K 0.32% 59
2023
Q2 		$1.87M Sell
29,290
-1,687
-5% -$113K 0.37% 55
2023
Q1 		$2.15M Sell
30,977
-255
-0.8% -$18K 0.46% 46
2022
Q4 		$2.25M Sell
31,232
-680
-2% -$51.3K 0.55% 39
2022
Q3 		$2.27M Sell
31,912
-2,534
-7% -$184K 0.58% 36
2022
Q2 		$2.65M Sell
34,446
-285
-0.8% -$21.7K 0.63% 38
2022
Q1 		$2.54M Sell
34,731
-2,736
-7% -$184K 0.54% 46
2021
Q4 		$2.34M Sell
37,467
-19,614
-34% -$1.15M 0.48% 55
2021
Q3 		$3.38M Sell
57,081
-1,268
-2% -$83.5K 0.78% 31
2021
Q2 		$3.9M Buy
58,349
+870
+2% +$56.7K 0.9% 28
2021
Q1 		$3.63M Buy
57,479
+49,746
+643% +$3.1M 0.94% 23
2020
Q4 		$480K Sell
7,733
-32
-0.4% -$1.97K 0.15% 105
2020
Q3 		$468K Buy
7,765
+52
+0.7% +$3.13K 0.16% 103
2020
Q2 		$454K Hold
7,713
– – 0.18% 90
2020
Q1 		$430K Buy
7,713
+1,250
+19% +$76.4K 0.18% 92
2019
Q4 		$415K Buy
+6,463
New +$370K 0.12% 112

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TBH Global Asset Management's BMY Position: Q1 2026 in Review

TBH Global Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 9.8% in Q1 2026, selling an estimated $45.3K and leaving 7,160 shares worth $434K. The position accounts for 0.09% of the portfolio, ranked #188.

TBH Global Asset Management first reported a position in BMY in Q4 2019 and has held it in 26 quarters since. The position peaked at $3.9M in Q2 2021. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • TBH Global Asset Management held 7,160 shares of Bristol-Myers Squibb worth $434K as of Q1 2026.
  • TBH Global Asset Management sold 777 Bristol-Myers Squibb shares in Q1 2026, an estimated $45.3K.
  • Bristol-Myers Squibb made up 0.09% of TBH Global Asset Management's portfolio in Q1 2026, its #188 holding.
  • TBH Global Asset Management first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 26 quarters since.
  • TBH Global Asset Management's Bristol-Myers Squibb position peaked at $3.9M in Q2 2021.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on TBH Global Asset Management's 13F filing for Q1 2026, filed 23 Apr 2026.